Literature DB >> 14718362

Long-term antioxidant intervention improves myocardial microvascular function in experimental hypertension.

Martin Rodriguez-Porcel1, Joerg Herrman, Alejandro R Chade, James D Krier, Jerome F Breen, Amir Lerman, Lilach O Lerman.   

Abstract

Hypertension increases oxidative stress, which can impair myocardial microvascular function and integrity. However, it is yet unclear whether long-term antioxidant intervention in early hypertension would preserve myocardial perfusion and vascular permeability responses to challenge. Pigs were studied after 12 weeks of renovascular hypertension without (n=8) or with daily supplementation of antioxidants (100 IU/kg vitamin E and 1 g vitamin C, n=6), and compared with normal controls (n=7). Myocardial perfusion and microvascular permeability were measured in vivo by electron beam computed tomography before and after 2 cardiac challenges (intravenous adenosine and dobutamine). Basal left ventricular muscle mass was also obtained. Mean arterial pressure was significantly increased in both groups of hypertensive animals (without and with antioxidants, 123+/-9 and 126+/-4 mm Hg, respectively, versus normal, 101+/-4 mm Hg; both P<0.05), but muscle mass was not different among the groups. The impaired myocardial perfusion response to adenosine observed in hypertensives (normal, +51+/-14%; P<0.05 versus baseline; hypertension, +14+/-15%; P=0.3 versus baseline) was preserved in hypertensive pigs that received antioxidants (+44+/-15%; P=0.01 compared with baseline). Long-term antioxidant intervention also preserved subendocardial microvascular permeability responses in hypertension. On the other hand, antioxidant intervention had little effect on the hypertension-induced myocardial vascular dysfunction observed in response to dobutamine. This study demonstrates that the impaired myocardial perfusion and permeability responses to increased cardiac demand in early hypertension are significantly improved by long-term antioxidant intervention. These results support the involvement of oxidative stress in myocardial vascular dysfunction in hypertension and suggest a role for antioxidant strategies to preserve the myocardial microvasculature.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718362     DOI: 10.1161/01.HYP.0000111834.03000.e4

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

1.  Non-invasive Monitoring of Angiogenesis in Cardiology.

Authors:  Martin Rodriguez-Porcel
Journal:  Curr Cardiovasc Imaging Rep       Date:  2009-02

2.  Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension.

Authors:  Martin Rodriguez-Porcel; Xiang-Yang Zhu; Alejandro R Chade; Beatriz Amores-Arriaga; Noel M Caplice; Erik L Ritman; Amir Lerman; Lilach O Lerman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-07       Impact factor: 4.733

3.  Relationship between surface area of nonperfused myocardium and extravascular extraction of contrast agent following coronary microembolization.

Authors:  Nasser M Malyar; Lilach O Lerman; Mario Gössl; Patricia E Beighley; Erik L Ritman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-04       Impact factor: 3.619

4.  Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease.

Authors:  Victor H Urbieta-Caceres; Xiang-Yang Zhu; Kyra L Jordan; Hui Tang; Kyle Textor; Amir Lerman; Lilach O Lerman
Journal:  Atherosclerosis       Date:  2011-10-12       Impact factor: 5.162

5.  Effects of chronic quercetin treatment in experimental renovascular hypertension.

Authors:  María Francisca García-Saura; Milagros Galisteo; Inmaculada Concepción Villar; Almudena Bermejo; Antonio Zarzuelo; Félix Vargas; Juan Duarte
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

6.  Reversal of experimental renovascular hypertension restores coronary microvascular function and architecture.

Authors:  Victor H Urbieta-Caceres; Xiang-Yang Zhu; Matthew E Gibson; Frederic D Favreau; Kyra Jordan; Amir Lerman; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2011-01-13       Impact factor: 2.689

7.  Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension.

Authors:  Alfonso Eirin; Barbara J Williams; Behzad Ebrahimi; Xin Zhang; John A Crane; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  J Hypertens       Date:  2014-01       Impact factor: 4.844

8.  Antioxidants improve early survival of cardiomyoblasts after transplantation to the myocardium.

Authors:  Martin Rodriguez-Porcel; Olivier Gheysens; Ramasamy Paulmurugan; Ian Y Chen; Karen M Peterson; Jürgen K Willmann; Joseph C Wu; Xiangyang Zhu; Lilach O Lerman; Sanjiv S Gambhir
Journal:  Mol Imaging Biol       Date:  2009-12-15       Impact factor: 3.488

9.  Monocyte chemoattractant proteins mediate myocardial microvascular dysfunction in swine renovascular hypertension.

Authors:  Jing Lin; Xiangyang Zhu; Alejandro R Chade; Kyra L Jordan; Ronit Lavi; Elena Daghini; Matthew E Gibson; Angelo Guglielmotti; Amir Lerman; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-23       Impact factor: 8.311

10.  Myocardial microvascular function during acute coronary artery stenosis: effect of hypertension and hypercholesterolaemia.

Authors:  Xiang-Yang Zhu; Elena Daghini; Alejandro R Chade; Daniele Versari; James D Krier; Kyle B Textor; Amir Lerman; Lilach O Lerman
Journal:  Cardiovasc Res       Date:  2009-05-07       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.